BLRX
BioLineRX
BLRX
BLRX
29 hedge funds and large institutions have $2.12M invested in BioLineRX in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 10 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
less ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
14% less capital invested
Capital invested by funds: $2.46M → $2.12M (-$339K)
40% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 10
Holders
29
Holding in Top 10
–
Calls
$451K
Puts
$219K
Top Buyers
| 1 | +$472K | |
| 2 | +$97.1K | |
| 3 | +$63.4K | |
| 4 |
JPMorgan Chase & Co
New York
|
+$36.1K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$12.5K |
Top Sellers
| 1 | -$382K | |
| 2 | -$168K | |
| 3 | -$54.6K | |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$42.5K |
| 5 |
LPL Financial
San Diego,
California
|
-$21K |